Why the study?
Does DOAC use at discharge improve long-term outcomes in older patients with acute ischemic stroke and atrial fibrillation compared to warfarin?
Does DOAC use at discharge improve long-term outcomes in older patients with acute ischemic stroke and atrial fibrillation compared to warfarin?
In older patients with atrial fibrillation and acute ischemic stroke, discharging on a DOAC rather than warfarin is associated with better long-term outcomes.
Answers are grounded in this paper and cite their sources.
May support DOAC preference at discharge in older AF stroke patients; leaves open causal confirmation in RCTs.
In patients with acute ischemic stroke and AF, DOAC use at discharge was associated with better long-term outcomes relative to warfarin.
No takes yet. Share an insight, caveat, or question.
Xian et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: